(Updates)
** Shares of Cryoport Inc CYRX.O fall 25.5% to $14.45
** Stock set for its biggest one-day pct fall in over 8
months
** The life sciences industry logistics support provider cut
its 2023 revenue forecast late on Wednesday, impacted by abrupt
slowdown in demand for its cryogenic freezer systems
** Co now expects full-year 2023 revenue in the range of
$233 mln-$243 mln compared with $270 mln-$290 mln forecast
previously
** Analysts on an average estimate 2023 revenue of $266.5
mln - Refinitiv
** Brokerage SVB Securities downgrades rating on stock to
"market perform" from "outperform", cuts PT to $10 from $30
** New PT represents a 48.5% downside to stock's last close
of $19.4
** The slash in forecast is a result of tighter spending at
small and small-mid cap biotechs for cell and gene therapy
clinical trials - SVB
** Overall slowdown in activity and lower capital spending
is impacting CYRX's cryogenic freezer business, particularly in
China, says brokerage
** Including session moves, stock down ~17% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))